PT93716A - Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo - Google Patents

Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo

Info

Publication number
PT93716A
PT93716A PT93716A PT9371690A PT93716A PT 93716 A PT93716 A PT 93716A PT 93716 A PT93716 A PT 93716A PT 9371690 A PT9371690 A PT 9371690A PT 93716 A PT93716 A PT 93716A
Authority
PT
Portugal
Prior art keywords
dissulfuret
antitumers
antibacterials
tritium
methyl
Prior art date
Application number
PT93716A
Other languages
English (en)
Other versions
PT93716B (pt
Inventor
George A Ellestad
William James Mcgahren
Martin Leon Sassiver
Philip R Hamann
Lois M Himann
Janis Upeslacis
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/339,343 external-priority patent/US5053394A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PT93716A publication Critical patent/PT93716A/pt
Publication of PT93716B publication Critical patent/PT93716B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lubricants (AREA)
  • Engine Equipment That Uses Special Cycles (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treating Waste Gases (AREA)
PT93716A 1989-04-14 1990-04-10 Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo PT93716B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33932389A 1989-04-14 1989-04-14
US07/339,343 US5053394A (en) 1988-09-21 1989-04-14 Targeted forms of methyltrithio antitumor agents

Publications (2)

Publication Number Publication Date
PT93716A true PT93716A (pt) 1990-11-20
PT93716B PT93716B (pt) 1996-08-30

Family

ID=26991573

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93716A PT93716B (pt) 1989-04-14 1990-04-10 Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo

Country Status (16)

Country Link
EP (1) EP0392384B1 (pt)
JP (1) JP2951684B2 (pt)
CN (2) CN1046333A (pt)
AT (1) ATE163293T1 (pt)
AU (1) AU633069B2 (pt)
CZ (1) CZ293228B6 (pt)
DE (1) DE69032051T2 (pt)
DK (1) DK0392384T3 (pt)
ES (1) ES2112244T3 (pt)
FI (1) FI100105B (pt)
GR (1) GR3026177T3 (pt)
IL (3) IL93733A (pt)
NO (2) NO176717C (pt)
NZ (1) NZ233148A (pt)
PT (1) PT93716B (pt)
SK (1) SK284270B6 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
EP0342341A3 (en) * 1988-05-17 1991-07-24 American Cyanamid Company Process for producing antitumor antibiotic ll-e33288gamma2
GB9120467D0 (en) * 1991-09-26 1991-11-06 Celltech Ltd Anti-hmfg antibodies and process for their production
US6015562A (en) * 1992-09-22 2000-01-18 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US5773001A (en) * 1994-06-03 1998-06-30 American Cyanamid Company Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US6441163B1 (en) * 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
CN108047287B (zh) * 2013-11-04 2021-04-27 辉瑞大药厂 用于合成加利车霉素衍生物的中间体和方法
EP3365025B1 (en) 2015-10-20 2020-07-15 Genentech, Inc. Calicheamicin-antibody-drug conjugates and methods of use
JP6917049B2 (ja) * 2017-02-22 2021-08-11 公立大学法人大阪 特定のサルファイド化合物に結合する抗体及びその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0276485B1 (en) * 1987-01-30 2002-06-12 American Cyanamid Company Dihydro derivatives of LL-E33288 antibiotics
ATE112172T1 (de) * 1987-10-30 1994-10-15 American Cyanamid Co Targetformer von antitumor-methyltrithioagenzien.

Also Published As

Publication number Publication date
FI100105B (fi) 1997-09-30
NO176717B (no) 1995-02-06
JPH02292294A (ja) 1990-12-03
AU633069B2 (en) 1993-01-21
NO932192D0 (no) 1993-06-14
ATE163293T1 (de) 1998-03-15
ES2112244T3 (es) 1998-04-01
DE69032051T2 (de) 1998-06-10
CZ293228B6 (cs) 2004-03-17
JP2951684B2 (ja) 1999-09-20
PT93716B (pt) 1996-08-30
CZ188490A3 (cs) 2000-08-16
IL115770A (en) 1999-03-12
EP0392384A3 (en) 1991-11-06
NZ233148A (en) 1996-02-27
NO176717C (no) 1995-05-16
NO901655D0 (no) 1990-04-11
IL93733A0 (en) 1990-12-23
IL93733A (en) 1996-01-19
FI901866A0 (fi) 1990-04-12
DE69032051D1 (de) 1998-03-26
NO901655L (no) 1990-10-15
NO932192L (no) 1990-10-15
EP0392384B1 (en) 1998-02-18
AU5324190A (en) 1990-11-01
CN1110280A (zh) 1995-10-18
NO177308C (no) 1995-08-23
DK0392384T3 (da) 1998-03-16
GR3026177T3 (en) 1998-05-29
CN1046333A (zh) 1990-10-24
IL115770A0 (en) 1996-01-19
CN1109041C (zh) 2003-05-21
EP0392384A2 (en) 1990-10-17
NO177308B (no) 1995-05-15
SK188490A3 (en) 2000-08-16
SK284270B6 (sk) 2004-12-01

Similar Documents

Publication Publication Date Title
PT94059A (pt) Processo para a preparacao de copolimetros hidrossoluveis, de n-vinilamidas
PT90295A (pt) Processo para a preparacao de biciclodionas substituidas por arilo ou heteroarilo
BR9003345A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
PT93716A (pt) Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo
PT88177A (pt) Processo para a preparacao de eteres contendo por exemplo, grupos azabiciclicos
BR8905777A (pt) Processo para preparacao de eteres de ciclohexenonoxima,aplicaveis como herbicidas
PT94226A (pt) Processo de preparacao de 1,2-dioxetanos que produzem quimioluminescencia por activacao dupla
PT89923A (pt) Processo para a preparacao de variantes da hiridina
PT90569A (pt) Processo para a preparacao de 2-piperazinil- ou 2-homopiperazinil-1,2,3,4-tetra-hidronaftalenos
PT91302A (pt) Processo para a preparacao de composicoes farmaceuticas contendo imidazo {2,1-a} isoquinolinas substituidas por 5-heteroarilo ou 5-arilo
BR9004539A (pt) Processo para a obtencao de 1,1,1,2-tetrafluoretano
FI951377A0 (fi) N-asetyylineuramiinihappojohdannaisten synteesi
PT93736A (pt) Processo para a preparacao de n,n'-ditrimetoxi-benzoil-piperazinas 2- substituidas
BR9003360A (pt) Processo para a obtencao de 1,1,1-trifluor-2-cloroetano
BR9206468A (pt) Processo para produzir solução aquosa de ácido hipocloroso.
BR9003346A (pt) Processo para a preparacao de 1,2-dicloro-1,1,2-trifluoretano
FR2650282B1 (fr) Procede de preparation de chitosan par n-desacetylation de chitine
BR8700465A (pt) Processo para a producao de um catalisador de mos2 promovido,processo para a producao de alcoois mistos,e alcoois mistos produzidos por esse processo
BR9407024A (pt) Processo para a preparação de 4,6-diamino-5-cianopirimidinas substituídas
ES2028834T3 (es) Metodo para la preparacion de accidos piridin-2,3-dicarboxilico.
PT94480A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de isoxazolin-3-ona uteis como antidepressivos
BR9007499A (pt) Processo para a preparacao de 2,4,6-trifluor-1,3,5-triazina
PT95518A (pt) Processo para a preparacao de 3-aroil-2-oxindole-1-carboxamidas
BR9404216A (pt) Processo para a preparação de tetracloro-1,4-benzoquinona
PT88952A (pt) Processo para a preparacao de avermectinas etiladas

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960529

PD3A Change of proprietorship

Free format text: WYETH HOLDINGS CORPORATION US

Effective date: 20031117

TE3A Change of address (patent)

Free format text: AMERICAN CYANAMID COMPANY US

Effective date: 20031117

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20110530